Hidradenitis Suppurativa: Bacteriological Study in Surgical Treatment

Overview

Journal Postepy Dermatol Alergol

Publisher Termedia

Specialty Allergy & Immunology

Date 2023 Jan 23

PMID 36686013

Authors

Marcin Gierek

Gabriela Ochala-Gierek

Diana Kitala

Wojciech Labus

Beata Bergler-Czop

Affiliations

Soon will be listed here.

Abstract

Introduction: Hidradenitis suppurativa (HS) is an inflammatory chronic disease of the hair follicles that presents with different lesions in the apocrine gland-bearing areas of the human body. There are many possible factors for HS. Acne inversa is not primarily considered to be an infectious disease. A variety of Gram-positive and Gram-negative bacteria have been found from the lesions sporadically.

Aim: To assess the bacteriological profile of HS before surgical treatment.

Material And Methods: We collected specimens for aerobic microbiological testing from 18 patients before surgical treatment in our hospital. The specimens were obtained from abscesses, directly from skin fistulas, on day 1 of hospitalisation.

Results: The most common bacteria in HS lesions were Staphylococcus aureus and Proteus mirabilis. In 4 patients we found multi-drug-resistant bacteria (MLSB, MRSA and A. baumannii).

Conclusions: Long-term antibiotic treatment can cause multi-drug resistance in strains collected in HS lesions.

Citing Articles

Antimicrobial Resistance Trends in Hidradenitis Suppurativa Lesions.

Koumaki D, Evangelou G, Maraki S, Rovithi E, Petrou D, Apokidou E J Clin Med. 2024; 13(14).

PMID: 39064287 PMC: 11278491. DOI: 10.3390/jcm13144246.

Transcriptomic Analysis of Hidradenitis Suppurativa: A Unique Molecular Signature with Broad Immune Activation.

Ben Abdallah H, Bregnhoj A, Iversen L, Johansen C Int J Mol Sci. 2023; 24(23).

PMID: 38069342 PMC: 10707244. DOI: 10.3390/ijms242317014.

Clinical and Ultrasonographic Characterization of Hidradenitis Suppurativa in Female Patients: Impact of Early Recognition of the Disease.

Di Cesare A, Rosi E, Amerio P, Prignano F Life (Basel). 2023; 13(8).

PMID: 37629487 PMC: 10455481. DOI: 10.3390/life13081630.

Systemic Antibiotic Therapy in Hidradenitis Suppurativa: A Review on Treatment Landscape and Current Issues.

Molinelli E, De Simoni E, Candelora M, Sapigni C, Brisigotti V, Rizzetto G Antibiotics (Basel). 2023; 12(6).

PMID: 37370297 PMC: 10295086. DOI: 10.3390/antibiotics12060978.

Laser speckle contrast analysis (LASCA): a new device in the diagnosis and monitoring of surgical treatment of hidradenitis suppurativa.

Gierek M, Bergler-Czop B, Slabon A, Labus W, Ochala-Gierek G Postepy Dermatol Alergol. 2023; 40(2):253-258.

PMID: 37312925 PMC: 10258702. DOI: 10.5114/ada.2023.126323.

References

Fimmel S, Zouboulis C . Comorbidities of hidradenitis suppurativa (acne inversa). Dermatoendocrinol. 2011; 2(1):9-16. PMC: 3084959. DOI: 10.4161/derm.2.1.12490. View

van der Zee H, Laman J, Boer J, Prens E . Hidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatments. Exp Dermatol. 2012; 21(10):735-9. DOI: 10.1111/j.1600-0625.2012.01552.x. View

Zouboulis C, Desai N, Emtestam L, Hunger R, Ioannides D, Juhasz I . European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol. 2015; 29(4):619-44. DOI: 10.1111/jdv.12966. View

Guet-Revillet H, Coignard-Biehler H, Jais J, Quesne G, Frapy E, Poiree S . Bacterial pathogens associated with hidradenitis suppurativa, France. Emerg Infect Dis. 2014; 20(12):1990-8. PMC: 4257786. DOI: 10.3201/eid2012.140064. View

Emelianov V, Bechara F, Glaser R, Langan E, Taungjaruwinai W, Schroder J . Immunohistological pointers to a possible role for excessive cathelicidin (LL-37) expression by apocrine sweat glands in the pathogenesis of hidradenitis suppurativa/acne inversa. Br J Dermatol. 2011; 166(5):1023-34. DOI: 10.1111/j.1365-2133.2011.10765.x. View

Delaunay J, Villani A, Guillem P, Tristan A, Boibieux A, Jullien D . Oral ofloxacin and clindamycin as an alternative to the classic rifampicin-clindamycin in hidradenitis suppurativa: retrospective analysis of 65 patients. Br J Dermatol. 2017; 178(1):e15-e16. DOI: 10.1111/bjd.15739. View

Jemec G, Wendelboe P . Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa. J Am Acad Dermatol. 1998; 39(6):971-4. DOI: 10.1016/s0190-9622(98)70272-5. View

Sartorius K, Lapins J, Jalal S, Emtestam L, Hedberg M . Bacteraemia in patients with hidradenitis suppurativa undergoing carbon dioxide laser surgery: detection and quantification of bacteria by lysis-filtration. Dermatology. 2006; 213(4):305-12. DOI: 10.1159/000096194. View

Pink A, Simpson M, Desai N, Dafou D, Hills A, Mortimer P . Mutations in the γ-secretase genes NCSTN, PSENEN, and PSEN1 underlie rare forms of hidradenitis suppurativa (acne inversa). J Invest Dermatol. 2012; 132(10):2459-2461. DOI: 10.1038/jid.2012.162. View

10.

Li C, Jiang M, Shen D, Xu H, Wang H, Yao X . Two novel mutations of the nicastrin gene in Chinese patients with acne inversa. Br J Dermatol. 2011; 165(2):415-8. DOI: 10.1111/j.1365-2133.2011.10372.x. View

11.

Sabat R, Jemec G, Matusiak L, Kimball A, Prens E, Wolk K . Hidradenitis suppurativa. Nat Rev Dis Primers. 2020; 6(1):18. DOI: 10.1038/s41572-020-0149-1. View

12.

Brook I, Frazier E . Aerobic and anaerobic microbiology of axillary hidradenitis suppurativa. J Med Microbiol. 1999; 48(1):103-105. DOI: 10.1099/00222615-48-1-103. View

13.

Jemec G, Faber M, Gutschik E, Wendelboe P . The bacteriology of hidradenitis suppurativa. Dermatology. 1996; 193(3):203-6. DOI: 10.1159/000246246. View

14.

Matusiak L, Bieniek A, Szepietowski J . Bacteriology of hidradenitis suppurativa - which antibiotics are the treatment of choice?. Acta Derm Venereol. 2014; 94(6):699-702. DOI: 10.2340/00015555-1841. View

15.

Satoh T, Mellett M, Contassot E, French L . Are neutrophilic dermatoses autoinflammatory disorders?. Br J Dermatol. 2016; 178(3):603-613. DOI: 10.1111/bjd.15105. View

16.

Lee C, Lee J, Park M, Park K, Bae I, Kim Y . Biology of : Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options. Front Cell Infect Microbiol. 2017; 7:55. PMC: 5346588. DOI: 10.3389/fcimb.2017.00055. View

17.

Lapins J, Jarstrand C, Emtestam L . Coagulase-negative staphylococci are the most common bacteria found in cultures from the deep portions of hidradenitis suppurativa lesions, as obtained by carbon dioxide laser surgery. Br J Dermatol. 1999; 140(1):90-5. DOI: 10.1046/j.1365-2133.1999.02613.x. View

18.

Pink A, Simpson M, Brice G, Smith C, Desai N, Mortimer P . PSENEN and NCSTN mutations in familial hidradenitis suppurativa (Acne Inversa). J Invest Dermatol. 2011; 131(7):1568-70. DOI: 10.1038/jid.2011.42. View

19.

Yazdanyar S, Jemec G . Hidradenitis suppurativa: a review of cause and treatment. Curr Opin Infect Dis. 2010; 24(2):118-23. DOI: 10.1097/QCO.0b013e3283428d07. View

20.

Fidel Jr P, Vazquez J, Sobel J . Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev. 1999; 12(1):80-96. PMC: 88907. DOI: 10.1128/CMR.12.1.80. View